Higashikagawa, Japan

Kazuha Tani

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 4 EPO patents. Top assignee: Teikoku Seiyaku Co., Ltd.. Active years: 2015-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuha Tani. Retrieved from https://idiyas.com/inventor/kazuha-tani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 1.8

ph-index = 1


Location History:

  • Higashikagawa, JP (2015 - 2016)
  • Sanuki, JP (2018)

Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kazuha Tani - Innovator in Transdermal Drug Delivery

Introduction

Kazuha Tani is an inventive mind based in Higashikagawa-shi, Japan. She has made significant strides in the field of transdermal drug delivery systems. Her innovative approach focuses on creating effective and safe methods for delivering medications through the skin.

Latest Patent Applications

Kazuha Tani's notable patent application is for a Ketoprofen-Containing Aqueous Adhesive Skin Patch. This water-based patch contains ketoprofen as an active ingredient, which provides high transdermal absorbability. The formulation ensures high safety and storage stability. The patch includes ketoprofen, an amine, and polyethylene glycol. Specifically, the added amount of ketoprofen in the paste ranges from 0.1 to 5% by weight, while the amine is added in an amount of 0.5 to 10% by weight, and polyethylene glycol is included at 5 to 30% by weight. Notably, diisopropanolamine is utilized as the amine in this innovative patch.

Conclusion

Kazuha Tani's contributions to the field of transdermal drug delivery highlight her innovative spirit and dedication to improving medical treatments. Her work on the ketoprofen-containing patch showcases her potential to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…